End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 18 | Health Care Up as Traders Await Policy Statement -- Health Care Roundup | DJ |
Mar. 18 | Stocks downbeat before central bank rate storm | AN |
Financials (USD)
Sales 2024 * | 60.42B | Sales 2025 * | 63.09B | Capitalization | 157B |
---|---|---|---|---|---|
Net income 2024 * | 7.89B | Net income 2025 * | 12.59B | EV / Sales 2024 * | 3.35 x |
Net Debt 2024 * | 45.61B | Net Debt 2025 * | 42.35B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
12.3
x | Employees | - |
Yield 2024 * |
6.13% | Yield 2025 * |
6.29% | Free-Float | 58.92% |
Latest transcript on Pfizer Inc
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
1st Jan change | Capi. | |
---|---|---|
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-5.94% | 145B |
- Stock
- Equities
- Stock Pfizer, Inc.
- Stock Pfizer Inc - Nyse